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Background: The Tax oncoproteins are transcriptional
regulators of viral expression involved in pathogenesis
induced by complex leukemogenic retroviruses (or delta-
retroviruses, i.e., primate T-cell leukemia viruses and bo-
vine leukemia virus). To better understand the molecular
pathways leading to cell transformation, we aimed to
identify cellular proteins interacting with Tax. Methods:
We used a yeast two-hybrid system to identify interacting
cellular proteins. Interactions between Tax and candidate
interacting cellular proteins were confirmed by glutathione
S-transferase (GST) pulldown assays, co-immunoprecipitation,
and confocal microscopy. Functional interactions between
Tax and one interacting protein, tristetraprolin (TTP), were
assessed by analyzing the expression of tumor necrosis
factor- (TNF-), which is regulated by TTP, in mammalian
cells (HeLa, D17, HEK 293, and RAW 264.7) transiently
transfected with combinations of intact and mutant Tax and
TTP. Results: We obtained seven interacting cellular pro-
teins, of which one, TTP, was further characterized. Tax and
TTP were found to interact specifically through their respec-
tive carboxyl-terminal domains. The proteins colocalized
in the cytoplasm in a region surrounding the nucleus of
HeLa cells. Furthermore, coexpression of Tax was associ-
ated with nuclear accumulation of TTP. TTP is an
immediate-early protein that inhibits expression of TNF-
at the post-transcriptional level. Expression of Tax re-
verted this inhibition, both in transient transfection ex-
periments and in stably transfected macrophage cell lines.
Conclusion: Tax, through its interactions with the TTP
repressor, indirectly increases TNF- expression. This
observation is of importance for the cell transformation
process induced by leukemogenic retroviruses, because
TNF- overexpression plays a central role in pathogene-
sis. [J Natl Cancer Inst 2003;95:1846 –59]
The primate T-cell lymphotropic viruses (PTLV-1, -2, and
-3) and bovine leukemia virus (BLV) are members of the Delta-
retrovirus genus of the Retroviridae family (1,2). These viruses
infect either T or B lymphocytes and can lead to hematologic or
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neurologic disorders (3,4). The prototype virus, human
T-lymphotropic virus type 1 (HTLV-1), propagates in CD4 or
CD8 T cells and, after extended latency periods of 30–50 years,
causes a rapidly fatal leukemia called adult T-cell leukemia/
lymphoma (ATL). Infection with HTLV-1 is also associated
with a degenerative neuromuscular disease referred to as tropical
spastic paraparesis or HTLV-1-associated myelopathy (5). In-
fection of cattle with BLV leads to diverse lymphoproliferative
manifestations, including tumors (lymphoma and lymphosar-
coma) and/or persistent lymphocytosis, which is characterized
by a stable increase in the number of circulating B cells. Another
member of this group of viruses, HTLV-2, does not appear to be
pathogenic, at least in non-immunosuppressed individuals. In-
fection with BLV or HTLV-1 results in the coordinate expres-
sion of several cellular genes, including those for various cyto-
kines, such as interleukin 2 (IL-2) (6–8), IL-6 (9,10),
granulocyte–macrophage colony-stimulating factor (11), and tu-
mor necrosis factor- (TNF-) (12–14). This aberrant expres-
sion of cytokines is thought to affect viral spread and disease
progression. For instance, TNF- plays a critical role in the
physiology of HTLV-1-associated myelopathy by impairing the
ability of astrocytes to take up extracellular glutamate. This
deregulation of glutamate levels may affect the functions and
survival of neurons and oligodendrocytes (15).
The mechanisms that underlie the process of leukemogenesis
caused by complex retroviruses are still not clearly understood.
Increasing evidence, however, supports an essential role for the
tax gene. Tax protein is a transcriptional activator of cellular
gene expression and is required for viral replication in vivo. Tax
positively regulates transcription of viral genes and also acti-
vates transcription of several cellular genes, including IL-2 and
its receptor, Bcl-xL, proliferating cell nuclear antigen (PCNA),
vimentin, TNF-, Krox 24, interferon 
, and transforming
growth factor (TGF)- [reviewed in (1)]. The cellular metabolic
pathways involved in gene regulation by Tax include cyclic
adenosine monophosphate (cAMP) response element binding
protein (CREB), nuclear factor B (NF-B), and the serum
responsive factor (SRF) transcription factors. Tax binds physi-
cally to members of the CREB/activation transcription factor
family, thereby increasing their affinity for the cAMP response
site [reviewed in (1)]. Tax also modulates the general transcrip-
tion machinery via the p300/CREB binding protein (CBP) and
p300/CBP-associated factor acetyltransferases (16–22). Activa-
tion of NF-B-responsive genes by Tax is mediated by the
interaction of Tax with the inhibitor of NF-B (IB) kinase
(23–26), phosphorylation-dependent degradation of the IB in-
hibitor, and subsequent release of NF-B into the nucleus.
Conversely, when transiently overexpressed, Tax also acts as a
transcriptional repressor of bax (27), p53 (28), cyclins A and D3
(29), and - and -polymerases (30), possibly interfering with
apoptosis and gene stability. Besides these activities, Tax is able
to promote and accelerate entry into the cell cycle by activating
cyclin-dependent kinases via its interaction with cyclin D3 (31–
34). Tax modulation of the cell cycle also occurs through at least
two other mechanisms: 1) Tax activates the promoter of the E2F
transcription factor and 2) Tax inhibits the p16INK cyclin-
dependent kinase repressor (35,36). Overexpression of Tax in
cells leads to various chromosomal abnormalities resulting from
DNA damage (37–39), inhibition of nucleotide excision repair
(40), and abrogation of the mitotic spindle assembly checkpoint
(41), all of which are thought to be essential steps in the
leukemogenic process. Finally, the oncogenic capacity of Tax
has been revealed by a series of transformation assays using
primary fibroblasts (42–44), rodent cell lines, blood lympho-
cytes (45–47), and transgenic mice (48–51).
Together, these results describe a complex interconnection of
pathways potentially regulated by Tax and support a key role of
this viral protein during the leukemogenic process. To further
dissect the mechanisms associated with transformation, we
aimed to identify cellular proteins interacting with Tax. We
report here the results of a genetic screen allowing the identifi-




Plasmid pBDTax was constructed by polymerase chain reac-
tion (PCR) amplification of the BLV tax gene using primers
5-TTTGTCGACTAATGGCAAGTGTTGTTGGTTGG-3 and
5-TTTCTGCAGTCAAAAAAGGCGGGAGAGCC-3. The tax
amplicon was cloned into vector pBDGal4 (Stratagene, Amster-
dam, The Netherlands), which contains the DNA binding do-
main of the yeast transactivator Gal4. Used as controls, plasmids
p53 and pLaminC (Stratagene) express the DNA binding do-
main of Gal4 fused to amino acids 72–390 of murine p53 and
amino acids 67–230 of human Lamin C, respectively. Plasmid
pSV40, which encodes a fusion protein of the Gal4-activating
domain and region 84–708 of the SV40 large T antigen, was
used as positive control. Plasmid pGexTax was obtained by PCR
amplification of the BLV tax gene with the primers 5-
TTTGGATCCATGGCAAGTGTTGTTGGTTGG-3 and 5-TT
TCTCGAGTCAAAAAAGGCGGGGAGAGCC-3; the ampli-
con was subsequently inserted into pGex-2T downstream of the
glutathione S-transferase (GST) sequences (Amersham Bio-
sciences, Roosendaal, The Netherlands). Plasmid pGexTax1
(provided by F. Bex, Université Libre de Bruxelles, Brussels,
Belgium) encodes the HTLV Tax-1 protein fused to GST.
The ovine TTP cDNA was obtained by reverse transcription
of total RNA isolated from sheep peripheral blood mononuclear
cells by using TRIzol and the SuperScript Preamplification Sys-
tem protocol (Invitrogen, Merelbeke, Belgium). TTP cDNA was
amplified by 36 cycles of PCR using the Pwo enzyme (Roche,
Brussels, Belgium) and the primers 5-ACATCCTTCGGCC
ATCTGC-3 and 5-AGCTGATCTGTACTAGGCAG-3. Vec-
tors pSGTTP and pEGFPTTP were constructed by subcloning
the TTP amplicon into pSG5 (Stratagene) and pEGFP-C1 (Clon-
tech, Erembodegem, Belgium), respectively. Plasmids hTTP(1–
230), hTTP(1–206), and hTTP(1–173) expressing influenza vi-
rus hemagglutinin–tagged mutants of human TTP were derived
from the wild-type hTTP vector by 3 end deletion of the TTP
open reading frame at codons 230, 206, and 173, respectively.
Plasmids pSGTax (43) and pTax1/pCMVTax/pIEXTax (pro-
vided by F. Bex, E. Wattel [Centre Léon Bérard, Lyon,
France], and K. T. Jeang [National Institutes of Health, Be-
thesda, MD]) are mammalian expression vectors for BLV Tax
and HTLV Tax-1 proteins, respectively. A series of plasmids
containing BLV tax mutants and variants were used:
pSGTax2XAsp, pSGTax106293, pSGSer76, pSGSer103,
pSGSer110, pSGSer264, pSGTyr1–2 (52), pDSPLOR, pD-
SPLORBglI, pDSPLORBalI-NdeI, pDSPLORSmaIRI, pD-
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SPLORStuI (53), pSGTax395, pSGRex (54), pSGTaxM1–5 (55),
pSG2.1 expressing both Tax and Rex, pSGTaxPT (which corre-
sponds to exons 1 and 3 of the tax cDNA cloned into pSG5), and
pSGTax(1–228) (which derives from pSGTax after digestion of the
tax open reading frame with EcoRI and ligation). Vectors coding
for HTLV Tax-1 mutants were pTax2–58, pTax3–6, pTax3–8,
pTax105–114, pTax94–105, pTax94–114, pTax284–353,
pTax337–353 (these plasmids encode Tax1 mutants harboring de-
letions between indicated residues); pTax313 (in which threonine
codon 313 of the tax gene was replaced by an alanine; provided by
K. T. Jeang); pTax300–301 (expressing a Tax protein mutated in
serines 300 and 301, the two major phosphorylation sites); pG148V
(obtained from F. Bex); pM22; and pM47 (encoding Tax proteins
that are selectively able to activate gene expression via the CREB/
ATF and NF-B pathways, respectively; provided by E. Wattel).
pSGTax1(1–244), which expresses a COOH-truncated mu-
tant, was made by deletion of the tax1 cDNA region encoding
residues between 244 and 353. Reporter plasmids pLTRCAT
(43), pLTR1CAT, pRSVCAT, and p3XTRECAT (provided by
D. Derse, National Cancer Institute-Frederick Cancer Research
and Development Center, Frederick, MD) harbor, respectively,
the BLV long terminal repeat (LTR), the HTLV-1 LTR, the
RSV (Rous Sarcoma Virus) promoter, and three repeats of the
12-O-tetradecanoylphorbol-13-acetate (TPA) response element
sequences cloned upstream of the chloramphenicol acetyltrans-
ferase (CAT) gene. Vector pEGFPMSX contains the human
Msx2 cDNA cloned into the pEGFP-C1 plasmid (Clontech). In
plasmid CMV3TNF, the CAT gene is driven by the cytomeg-
alovirus (CMV) promoter and is controlled by the 3 untrans-
lated region (UTR) of the TNF- mRNA. Plasmid
CMV3TNFUA– is the corresponding control plasmid lacking
the AU-rich element of the UTR (56).
Yeast Two-Hybrid System
This technique is based on the coexpression of two hybrid
proteins, one containing Tax fused to the yeast Gal4 binding
domain and the other corresponding to a cellular protein linked
to the Gal4 activation domain. Interaction between Tax and a
cellular protein creates a functional Gal4 transcription factor
whose activity can be selected and quantified.
A human placenta cDNA library was inserted into vector
pACT2 (Clontech) downstream of the yeast Gal4 activation
domain and transformed using the LiAc/polyethylene glycol
protocol into yeast PJ696 MATa (genotypes trp1–901,
leu2–3, 112, ura3–52, his3–200, gal4, gal80, GAL2-
ADE2, LYS2::GAL1-HIS3, and met2::GAL7-lac; details on
the strain are available from Clontech and Stratagene). Yeast
cells were plated onto synthetic dropout medium lacking
leucine, scraped, counted, and stored at 70 °C. PJ696
MAT yeast, which are PJ696 MATa yeast containing the
URA3 YEp50 vector (Stratagene), were transfected with plas-
mid pBDTax and plated onto synthetic dropout medium lack-
ing tryptophan and uracil to select for the bait plasmid and the
mating phenotype. PJ696 MATa cells transformed with the
cDNA library were mated with PJ696 MAT yeast containing
pBDTax in YPAD medium (1% bacto-yeast extract, 2%
bacto-peptone, 2% glucose, and 0.6% adenine) for 4 hours.
Cells were transferred to synthetic dropout solid medium
lacking uracil, leucine, tryptophan, and histidine and supple-
mented with 2 mM 3-amino-1,2,4-triazole (Sigma, Bornem,
Belgium) to reduce background of histidine selection. Five
days after mating, colonies were assayed for -galactosidase
expression. To this end, colonies were replicated on Whatman
filters, grown overnight in YPAD medium, lysed in liquid
nitrogen, and incubated in Z buffer (60 mM Na2HPO4, 40 mM
NaH2PO4, 10 mM KCl, 1 mM Mg2SO4) containing 0.33
mg/mL of the -galactosidase substrate X-gal (Eurogentec,
Seraing, Belgium). Positive colonies were cultivated in syn-
thetic dropout liquid medium lacking uracil, leucine, trypto-
phan, and histidine, and plasmid DNA was isolated and
transformed by electroporation into Escherichia coli HB101.
Bacteria were then plated into M9 minimal medium contain-
ing dropout nutrients but lacking leucine (57). The plasmids
were extracted by using Qiagen columns (Qiagen Westburg,
Leusden, The Netherlands), and the inserts were sequenced.
Quantification of -Galactosidase Activity
Cultures were grown overnight in synthetic dropout medium
lacking uracil, leucine, tryptophan, and histidine, diluted fivefold
in YPAD medium, and incubated until the optical density at 600
nm (OD600) reached 0.5–0.8. After one wash in Z buffer, the
yeast cells were lysed by three freeze–thaw cycles using liquid
nitrogen. Cell lysates were then resuspended in 0.7 mL of Z
buffer containing 0.27% -mercaptoethanol and 160 L of
ortho-nitrophenyl--D-galactopyranoside at 4 mg/mL in Z
buffer, as a substrate of -galactosidase. After a 1-hour incuba-
tion at 30 °C, the reactions were stopped by the addition of 400
L of 1 M Na2CO3, and the OD420 was determined.
GST Pulldown Assay
The prokaryotic expression plasmids pGexTax, pGexTax1,
and pGex-2T were transformed into the HB101 strain of E. coli.
Overnight cultures were diluted sixfold in fresh NZY medium
(Invitrogen) containing ampicillin at 100 g/mL and incubated
until the OD600 reached 0.7. After induction with 1 mM isopro-
pylthiogalactoside, bacteria were allowed to grow for an addi-
tional 3 hours. Bacteria were then harvested, washed with
phosphate-buffered saline (PBS), and lysed by sonication and by
incubation for 3 hours at 4 °C in the presence of 1% Triton
X-100. After centrifugation at 10 000g for 15 minutes at 4 °C,
the supernatant was mixed with glutathione-Sepharose beads
(Amersham Biosciences) for 1 hour at 4 °C. Finally, the beads
were washed four times with PBS and stored at 4 °C as a 15%
suspension in the presence of a mixture of protease inhibitors
(Complete; Roche). The amount of GSTTax, GSTTax1, or GST
polypeptides bound to the beads was quantified using the Bio-
Rad assay (Bio-Rad, Nazareth, Belgium). For the GST pulldown
assay, equal amounts of fusion proteins were added to 5 L of
rabbit reticulocyte lysates (in vitro transcription–translation;
Promega, Leiden, The Netherlands) programmed with pS-
GTTP plasmid in the presence of a mixture of 35S-methionine
and 35[S]-cysteine (Promix; Amersham Biosciences). After
gentle shaking for 3 hours at 4 °C in NETN binding buffer
(200 mM NaCl, 20 mM Tris–HCl [pH 8], 1 mM EDTA) and
0.5% Nonidet P-40 [NP40]), the beads were washed four
times in binding buffer. Bound proteins were eluted in sodium
dodecyl sulfate (SDS) sample buffer, resolved on a 12.5%
SDS–polyacrylamide gel, soaked in amplifying solution (En-
lightning; PerkinElmer Life Sciences, Schwadorf, Austria),
and visualized by autoradiography.
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Co-immunoprecipitation
HeLa–Tat cells (provided by V. Ciminale, University of
Padua, Padua, Italy) were cultivated at 37 °C in a 5% CO2–air
humidified atmosphere in Dulbecco’s modified Eagle medium
supplemented with 10% fetal bovine serum, penicillin at 100
U/mL, amphotericin B at 0.25 g/mL, streptomycin at 100
g/mL, and 1 mM sodium pyruvate. One day before transfec-
tion, the cells were divided and seeded at a density of 3.5  105
to 5  105 cells per 10–30 cm2. The cells were next transfected
with 2–3 g of plasmid DNA by using Lipofectamine Reagent
(Invitrogen) or GeneJammer (Stratagene) according to the man-
ufacturer’s instructions.
Thirty hours after transfection, the cells were washed in PBS,
scraped from the dish, and lysed in NET buffer (150 mM NaCl,
5 mM EDTA, 50 mM Tris–HCl [pH 8], 0.5% NP40, and 0.25%
sodium deoxycholate) containing proteolytic inhibitors (Com-
plete; Roche). The lysates were then immunoprecipitated with
rabbit anti-hemagglutinin antibody (final concentration  0.01
g/L; Santa Cruz Biotechnology, Santa Cruz, CA) and with
Protein A-Sepharose beads (Roche). The immunoprecipitates
were washed three times in NET buffer and once in TNE (10
mM Tris–HCl [pH 8.3], 150 mM NaCl, and 1 mM EDTA) and
subjected to electrophoresis on a denaturing polyacrylamide gel.
After transfer of the proteins to polyvinylidene difluoride mem-
branes, the filters were saturated with 1% Blocking Reagent
(Roche), incubated overnight with anti-Tax antibodies (500-fold
dilution), washed in TBST (50 mM Tris–HCl [pH 7.5], 150 mM
NaCl, and 0.1% Tween 20), and antibody binding was revealed
by chemiluminescence using horseradish peroxidase–conju-
gated anti-mouse immunoglobulin antibody (1000-fold dilu-
tion), according to the manufacturer’s instructions (Roche).
Confocal Microscopy
Twenty hours after transfection, 3.5  105 to 5  105
HeLa–Tat cells per 10–30 cm2 were fixed in 3.7% formaldehyde
(20 minutes at 4 °C), permeabilized with 0.1% NP40 (10 min-
utes), and incubated with anti-Tax antibodies (200-fold-diluted
Tax monoKI for HTLV-1 and 5A5 monoclonal antibodies and
L75 rabbit anti-Tax COOH-peptide for BLV, 1000-fold dilution)
and then with Alexa 546-coupled anti-mouse or anti-rabbit im-
munoglobulin conjugates (1000-fold dilution; Molecular Probes,
Leiden, The Netherlands) for 1 hour at 37 °C. After nuclear
fixing with TOPRO-3 (a DNA intercalating fluorescent dye;
Molecular Probes) and fixing with mounting medium (Prolong
Antifade kit; Molecular Probes), the cells were analyzed using a
Zeiss fluorescence confocal microscope (Axiovert 200 with
LSM 510; Carl Zeiss Microscopy, Jena, Germany).
CAT Assays
Two micrograms of reporter plasmids (pLTRCAT, pLTR1CAT,
pRSVCAT, p3XTRECAT, CMV3TNF, and CMV3TNFUA–)
and different amounts of effector vectors (pSGTax, pTax1, and
pSGTTP) were transfected into 3  105 HeLa–Tat, D17, or
HEK 293 cells by means of Lipofectamine Reagent. Forty-eight
hours after transfection, cells were washed three times in PBS
and lysed by three freeze–thaw cycles; CAT activities were then
determined as described previously (55). 14C-acetylated chlor-
amphenicol migrating into the Econofluor (PerkinElmer Life
Sciences) scintillation medium was counted at regular intervals
by a Packard analyzer (Packard BioScience, Meriden, CT).
Fig. 1. Tristetraprolin (TTP) interacts with human T-lymphotropic virus 1
(HTLV-1) and bovine leukemia virus (BLV) Tax proteins in yeast and in
vitro. A) PJ696 yeast cells transformed with different vectors (pADTTP,
pBDTax, p53, pLaminC, and/or pSV40, as indicated) were cultivated in
YPAD medium, and -galactosidase activity in cell lysates was determined
using ortho-nitrophenyl--D-galactopyranoside as a substrate. Data represent
the mean values of three independent experiments. Error bars indicate 95%
confidence intervals. B) TTP protein was synthesized using rabbit reticulo-
cyte lysates programmed with pSGTTP vector in the presence of 35S-labeled
methionine and cysteine. Lysate was mixed with equal amounts of glutathi-
one S-transferase (GST), GSTTax-1, or GSTTax proteins bound to
glutathione-Sepharose beads. After incubation, the mixtures were subjected
to electrophoresis on a 12.5% sodium dodecyl sulfate–polyacrylamide gel,
and bands were revealed by autoradiography. A representative experiment of
three is shown. C) HeLa cells were transfected with Tax and TTP expression
vectors, as indicated. Twenty-four hours after transfection, cells were lysed
and the TTP protein was immunoprecipitated with an influenza virus hem-
agglutinin–specific antibody. Protein complexes were then analyzed by west-
ern blot using anti-Tax antibodies. In lanes labeled “no IP,” the immunopre-
cipitation step was omitted. * indicates nonspecific binding. Tax indicates
the carboxyl terminal–truncated mutant of Tax. D) Schematic representation
of the Tax and TTP domains involved in binding. PPPP are the tetraproline
repeats in TTP and 2xC8C5C3H are the zinc finger–like structures in TTP.
The carboxyl-terminal end of Tax has been involved in p300/CBP-associated
factor (PCAF) interaction (transactivation domain). Amino acids 228/244
and 309/353 correspond to BLV/HTLV-1 Tax residues, respectively.
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Fig. 2. Tristetraprolin (TTP) and Tax colocalize in mammalian cells, as shown
by confocal microscopy. A) HeLa–Tat cells were transfected with pEGFPC1
(encoding green fluorescent protein; GFP), pEGFPTTP (expressing a fusion
polypeptide between GFP and TTP; GFPTTP), pEGFPMSX (Msx is another
protein binding to Tax), pTax1, or pSGTax (coding for human T-lymphotropic
virus 1 [HTLV-1] Tax-1 or bovine leukemia virus [BLV] Tax, respectively), as
indicated. Twenty hours after transfection, cells were fixed, permeabilized, and
labeled with Tax-specific antibodies and an Alexa 546-conjugated secondary
antiserum. Finally, labeled cells were stained with TOPRO-3 and analyzed with
a confocal microscope (Zeiss LSM510 coupled with an Axiovert 200 micro-
scope). Merge corresponds to the simultaneous acquisition of all three fluoro-
chromes. B) The fluorescence intensities (graphs) were assessed along the red
line segments (drawn on the photographs on left). The green, orange, and red
lines in the profiles correspond to the relative intensities of GFP, Alexa 546, and
TOPRO-3, respectively. White arrows indicate colocalization between Tax
(BLV Tax [top] and HTLV-1 Tax [Tax-1; bottom]) and TTP. Redistribution of
TTP from the cytoplasm to the nucleus in the presence of Tax is indicated by a
black arrow. (Continued on facing page).
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Fig. 2. (Continued from facing page).
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Titration of TNF- in Macrophage Cell Lines
RAW-Tax, RAW-Tax1, RAW-TTP, RAW-TaxTTP,
RAW-Tax1TTP, and RAW-pSG5c were derived from
RAW 264.7 macrophages after cotransfection with plasmid
pRc/CMVpSGTax, pTax1, pSGTTP, pSGTaxpSGTTP,
pTax1pSGTTP or the empty vector pSG5c, respectively.
Cells were transfected by means of Lipofectamine and cul-
tured in Dulbecco’s modified Eagle medium supplemented
with 5% fetal calf serum, 1 mM sodium pyruvate, penicillin at
100 U/mL, and streptomycin at 100 g/mL. After 48 hours at
37 °C, cells were selected with 1 mg/mL G418 sulfate for 1
week, and pools of clones were further maintained in the
presence of reduced concentrations of the antibiotic (0.4
mg/mL of G418 sulfate). Cells were plated at a density of 8
 105 cells in six-well dishes and stimulated with lipopoly-
saccharide (LPS at 100 ng/mL). TNF- production in the
culture supernatants was determined 6 hours after stimulation
with an enzyme-linked immunosorbent assay (Biosource In-
ternational, Nivelles, Belgium) according to the manufactur-
er’s instructions.
RESULTS
Cellular Proteins Interacting With Tax
To identify cellular factors interacting with Tax, we per-
formed a genetic screen based on the two-hybrid methodology.
We used Tax as a bait (vector pBDTax) to screen a human
placenta cDNA library containing cDNAs fused to the Gal4
transcriptional activation domain. After two rounds of selection
and titration of -galactosidase activity, Tax-binding clones
(n 7) were isolated and sequenced. They were found to encode
Tax interaction protein 1 (GenBank accession number
AF028823), Msx2 (BAA06549), transducin beta chain 2 (XP
005013), human glucose transporter (K03195), pyrroline-5-
carboxylate dehydrogenase (U24266), an unknown protein
(KIAA0184), and human TTP (M92844). Here, we present the
characterization of one of these clones, TTP, a protein already
known to be involved in TNF- regulation (58).
First, the strength and specificity of the interaction between
Tax and TTP were estimated by titration of -galactosidase
activity (Fig. 1, A). Substantial activity was obtained by the
coordinate action of pADTTP and pBDTax (lane 1) but not with
the empty vectors alone or in combination with nonspecific
sequences (lanes 2, 3, and 4). Only a weak signal was measured
with pBDTax alone (lane 2), indicating that Tax contains an
activation domain, as described previously (59,60). The
-galactosidase activities resulting from coexpression of
pADTTP and pBDTax approached the -galactosidase activity
of the positive control (pSV40p53, lane 5), supporting the
notion that the interaction between Tax and TTP was strong and
specific. Under similar conditions, a TTP-related protein,
TIS11b/Berg-36/ERF1 (X99404), did not exhibit substantial
binding to Tax (data not shown).
To further confirm the specificity of the interaction between
Tax and TTP, GST pulldown assays were performed. TTP was
pulled down by Tax proteins from HTLV-1 (GSTTax-1) and
BLV (GST–Tax) but not by GST alone (Fig. 1, B). Similar
results were obtained from co-immunoprecipitation assays using
lysates from cells transfected with Tax and TTP expression
vectors (Fig. 1, C, lanes 1 and 4 for BLV Tax and lanes 1 and 5
for HTLV Tax-1, respectively).
To identify the domains of Tax required for binding, a
series of Tax mutants (n  22 and n  14 for BLV Tax and
HTLV Tax-1, respectively; see “Materials and Methods”
section) were tested under similar conditions. Among these,
the majority of Tax mutants or variants retained the ability to
interact with TTP (Fig. 1, C, lane 9 for BLV Tax and lanes
9 –11 for HTLV Tax-1; and data not shown). Only a large
carboxyl-terminal truncation (plasmid pSGTax(1–228); Fig.
1, C, lane 8) abrogated binding, indicating that residues
228 –309 of BLV Tax belong to the interaction domain. The
corresponding deletion in HTLV Tax-1 (at position 244) also
abolished the interaction between Tax1 and TTP (data not
shown). Interestingly, the region at positions 244 –353 has
been identified as an activation-specific region and a p300/
CBP-associated factor binding domain (18) (Fig. 1, D). A
similar approach with TTP mutants identified residues 173–
326 as being required for Tax binding (Fig. 1, C, lanes 5–7 for
BLV Tax and lanes 6 – 8 for HTLV Tax-1). It thus appears
that both the Tax and TTP carboxyl-terminal domains are
involved in their mutual binding (Fig. 1, D). These findings
suggest that the Tax proteins bind specifically to TTP in vitro,
further demonstrating the specificity of their interaction.
Colocalization of Tax and TTP in Mammalian Cells
We next performed confocal microscopy to assess the
subcellular localizations of Tax and TTP in mammalian cells.
For this purpose, HeLa–Tat cells, previously shown to be
particularly convenient for microscopic examination, were
transfected with expression vectors for HTLV Tax-1 (pTax1),
BLV Tax (pSGTax), TTP tagged with green fluorescent pro-
tein (pEGFPTTP) and, as controls, GFP alone (pEGFPC1) or
GFPMSX (a hybrid between GFP and Msx2, another protein
interacting with Tax). Both BLV Tax and HTLV Tax-1 were
localized in the nucleus (stained by TOPRO-3) and in the
cytoplasm of the transfected cells, as revealed by specific Tax
antibodies and Alexa 546 conjugates (Fig. 2, A: TAX and
TAX-1). Under these experimental conditions, substantial
amounts of Tax were thus found in the cytoplasm, suggesting
a possible role in different subcellular compartments, as
indicated by other studies (61,62). In contrast, the GFPTTP
protein yielded mainly a cytoplasmic pattern, as previously
reported in cycling cells (63), whereas GFP alone did not
localize to a defined organelle (Fig. 2, A: GFPTTP and GFP).
Finally, Msx2 was nuclear, but considerable staining was also
observed in the cytoplasm (GFPMSX).
Coexpression of Tax and TTP provoked a dramatic change in
the localization of TTP, with two patterns being observed. First,
TTP was more concentrated in the nucleus of the cells in the
presence of Tax than in its absence, but not in their nucleolus
(Fig. 2, B, black arrows in the fluorescence intensity profiles,
compare with GFPTTP in Fig. 2, A). It thus appears that coex-
pression with Tax directs TTP into the nuclear compartment.
Second, Tax and TTP colocalized in the cytoplasm in a region
surrounding the nucleus, as revealed by the perfect match of the
green (TTP) and orange (Tax) fluorochromes (Fig. 2, B, white
arrows). In contrast, no colocalization occurred between Tax and
GFP alone, and a different profile was generated by Tax and
Msx2 coexpression (Fig. 2, B: GFP and GFPMSX). Based on
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confocal microcopy, we thus conclude that Tax and TTP colo-
calize in cells, further supporting the specificity of their
interaction.
Tax Transactivation in the Presence of TTP
To address the biologic significance of the interaction be-
tween Tax and TTP, we first analyzed the ability of Tax to
activate viral transcription in the presence of TTP. To this end,
expression vectors encoding BLV or HTLV Tax-1 proteins were
cotransfected into HeLa cells together with reporter plasmids
(pLTRCAT or pLTR1CAT) harboring the viral promoter se-
quences cloned upstream of the CAT gene. Forty-eight hours
after transfection, HeLa cells were harvested and CAT activities
were determined in the lysates. In the presence of Tax, an
increase in the levels of CAT activity revealed the activation of
LTR-directed gene expression, as expected (Fig. 3, compare
lanes 1 and 2 on panels A and B). In the presence of TTP, the
ability of Tax to transactivate the LTR promoters was inhibited
in a dose-dependent manner (Fig. 3, A, lanes 3–5 and 3–4 for
BLV and HTLV-1, respectively). In fact, it was possible to
nearly completely abolish Tax transactivation in the presence of
high doses (1000 ng) of TTP vector (panel A, lane 5, and panel
B, lane 4). As shown by western blot, inhibition of transactiva-
tion was not due to a decrease in the levels of Tax but rather was
linked to TTP expression (Fig. 3, A and B, lower panels).
Similar results were obtained with different cell lines: canine
D17 cells (Fig. 3, C, lanes 1–9) and HEK 293 cells (data not
shown). As a control for specificity, equivalent amounts of TTP
Fig. 3. Tristetraprolin (TTP) inhibits Tax transactivation of the viral long
terminal repeat (LTR) promoter during transient transfection experiments. A)
The pLTRCAT reporter construct (2 g), the effector plasmid pSGTax (encod-
ing bovine leukemia virus [BLV] Tax; 10 ng), and different amounts of hTTP
(coding for human TTP; as indicated in nanograms) were transfected into HeLa
cells. Chloramphenicol acetyltransferase (CAT) activities were determined from
the lysates 48 hours after transfection. An aliquot from these lysates was
separated on a 12.5% sodium dodecyl sulfate (SDS)–polyacrylamide gel, and a
western blot was performed using anti-BLV Tax or anti-influenza virus hemag-
glutinin (HA) antibodies. White arrows indicate the positions of Tax and TTP
proteins. B) The pLTR1CAT reporter construct (2 g), the effector plasmid
pTax1 (encoding HTLV Tax-1; 10 ng), and different amounts (in nanograms) of
hTTP (coding for human TTP) were transfected into HeLa cells. CAT activities
were determined from the lysates 48 hours after transfection. An aliquot from
these lysates was separated on a 12.5% SDS–polyacrylamide gel, and a western
blot was performed using anti-HTLV Tax-1 or anti-HA antibodies. White
arrows indicate the positions of Tax1 and TTP proteins. C) Two micrograms of
reporter constructs (pLTRCAT, pLTR1CAT, pRSVCAT, and p3XTRECAT)
and 10 ng of effector plasmids (pSGTax or pHTLVTax1 coding for BLV Tax
[lanes 1–5] and HTLV Tax-1 [lanes 6–9], respectively) were transfected into
D17 cells with different amounts (in nanograms) of pSGTTP vector (for TTP).
CAT activities were determined 48 hours after transfection. As a control for
specificity, equivalent amounts of TTP plasmid did not affect the promoter of
Rous Sarcoma Virus (pRSVCAT) or the p3xTRECAT reporter containing
three repeats of 12-O-TPA response elements (lanes 10 –13). D) Two micro-
grams of reporter constructs (pLTRCAT, pLTR1CAT) and 10 ng of effector
plasmids (pSGTax or pHTLVTax1 coding for BLV Tax and HTLV Tax-1,
respectively) were transfected into HeLa cells with different amounts (in
nanograms) of hTTP vector (for TTP) or carboxyl terminal–truncated mu-
tants hTTP(1–173), hTTP(1–206), and hTTP(1–230). CAT activities were
determined 48 hours after transfection. An aliquot from these lysates was
separated onto a 12.5% SDS–polyacrylamide gel, and a western blot was
performed using anti-HA antibodies (for HA-tagged TTP proteins). White
arrows indicate that mutant hTTP(1–173) does not inhibit Tax-dependent
transactivation.
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plasmid did not affect the promoter of RSV (pRSVCAT) or the
p3xTRECAT reporter gene containing three repeats of TPA
response elements (Fig. 3, C, lanes 10–13). To identify the TTP
domain involved in inhibition of Tax transactivation, vectors
expressing truncated versions of TTP were analyzed (Fig. 3, D).
Deletion of the carboxyl-terminal end abrogated the function
(plasmid pTTP(1–173); lanes 8, white arrows). The absence of
TTP-associated inhibition was not the consequence of a lack of
protein expression (western blots in Fig. 3, D). We conclude that
TTP specifically impedes Tax-dependent transactivation of both
BLV and HTLV-1 LTRs but does not alter gene expression
controlled by two other promoters (RSV and TRE).
TTP Function in the Presence of Tax
The major function of TTP is to interact with the AU-rich
element present in the 3 UTR of TNF- mRNA (58). This
interaction is associated with a concomitant post-transcriptional
regulation of TNF-, leading to a decrease in TNF- mRNA
stability (64–66). Post-transcriptional regulation of TNF- was
evaluated in transient transfection experiments using a reporter
construct harboring the CAT gene placed under control of the
CMV promoter and 3 UTR sequences of TNF- (plasmid
CMV3TNF) (56,67) (Fig. 4, A). Transfection of this reporter
into HeLa cells led to the expression of CAT activity that was
arbitrarily normalized to 100% (lane 1). Increasing doses of TTP
vector (10–810 ng) induced a gradual reduction in the levels of
CAT enzyme (lanes 2–6), revealing the ability of TTP to inhibit
3 UTR-dependent expression. As a control, no inhibition of
CAT activity was observed when TTP was coexpressed with the
CMV3TNFUA– reporter lacking the AU-rich element of the
TNF- mRNA (Fig. 4, A, lanes 7–12).
To assess the ability of the BLV Tax and HTLV Tax-1
proteins to interfere with TTP function, increasing doses of
the pSGTax and pTax1 vectors were included in the trans-
fection mixtures. Inhibition of CMV3TNF induced by TTP
(Fig. 4, B, compare lanes 1 and 2) was reverted in a dose-
dependent manner by coexpression of BLV Tax (lanes 3–5),
with levels reaching 80% of those seen in the absence of TTP.
HTLV Tax-1 was even more efficient in restoring CAT ac-
tivity driven by the CMV3TNF reporter (Fig. 4, C, lanes
3–5). As controls, cotransfection of pSGTax or pTax1 did not
affect the expression of the CMV3TNFUA– reporter, ex-
Fig. 4. Tax reverts tristetraprolin (TTP) in-
hibition in transient transfection assays. A)
HeLa–Tat cells were transfected with 2 g
of either CMV3TNF or CMV3TNFUA–
reporter plasmids and increasing amounts (in
nanograms) of TTP expression vector (pS-
GTTP). Forty-eight hours after transfection,
chloramphenicol acetyltransferase (CAT)
activities were determined. Data are the
mean values of relative CAT activities of
two independent experiments. B) pSGTTP
(30 ng) was cotransfected into HeLa–Tat
cells with 2 g of reporter plasmids
(CMV3TNF or CMV3TNFUA–) and dif-
ferent quantities of bovine leukemia virus
(BLV) Tax vector (pSGTax), as indicated.
Data are the means of three independent
experiments. Error bars indicate 95% confi-
dence intervals (CIs). C) pSGTTP (30 ng)
was cotransfected into HeLa–Tat cells with 2
g of reporter plasmids (CMV3TNF or
CMV3TNFUA–) and different quantities of
HTLV-1 Tax vector (pTax1 for Tax-1),
as indicated. Data are the means of three
independent experiments. Error bars in-
dicate 95% CIs. D) pSGTTP (30 ng) was
cotransfected into HeLa–Tat cells with 2
g of reporter plasmids (CMV3TNF or
CMV3TNFUA–) and 90 ng of vectors
coding for wild-type BLV Tax and mu-
tants, as indicated. Data are the means of
two or three independent experiments.
Error bars indicate 95% CIs (no error
bars appear if only two experiments were
performed). E) pSGTTP (30 ng) was co-
transfected into HeLa–Tat cells with 2
g of reporter plasmids (CMV3TNF or
CMV3TNFUA–) and 90 ng of vectors
coding for wild-type HTLV-1 Tax (pTax1)
and mutants, as indicated. Data are the
means of two or three independent exper-
iments. Error bars indicate 95% CIs (no
error bars appear if only two experiments
were performed).
1854 ARTICLES Journal of the National Cancer Institute, Vol. 95, No. 24, December 17, 2003
cluding a direct activation of the CMV promoter by Tax (Fig.
4, B and C, lanes 6 –10).
To identify the Tax domain required for TTP repression, a
series of Tax mutants were tested under similar conditions
(the number of mutants used for BLV Tax and HTLV Tax-1
were 22 and 14, respectively). Among these, only the car-
boxyl terminal–truncated mutants, BLV pSGTax(1–228)
(Fig. 4, D, white arrow) and HTLV pSGTax1(1–244) (Fig. 4,
E, white arrow) had lost their ability to revert TTP inhibition.
Thus, the potential inhibitory effect exerted by Tax resides in
the domain that interacts with TTP (see Fig. 1, C). Together,
our results demonstrate that, in transient transfection experi-
ments, Tax reverts TNF- 3 UTR-dependent inhibition in-
duced by TTP and that this function requires the carboxyl-
terminal domain of Tax.
Modulation of TNF- Expression by Tax and TTP
To further assess the functional interplay between TTP and
Tax, expression of TNF- was directly evaluated in macro-
phages in the presence of both proteins. For this purpose, RAW
264.7 macrophages were stably transfected with various com-
binations of expression vectors for TTP and Tax (pSGTax for
BLV or pTax1 for HTLV-1), as indicated in Fig. 5. In the
absence of LPS (Fig. 5, A, unstimulated), basal levels of
TNF- were low, except in the presence of Tax (RAW-Tax
and RAW-Tax1 cells). In cells expressing both Tax and TTP
(RAW-TaxTTP and RAW-Tax1TTP), secretion of TNF-was
completely abolished. Under these conditions, TTP thus coun-
teracted the activation of TNF- induced by Tax. When RAW
264.7 macrophages were stimulated with LPS (Fig. 5, B),
TNF- synthesis was stimulated, reaching up to 5000 pg/mL of
supernatant (RAW or RAW-pSG5 stably transfected with an
empty vector). LPS stimulation of TNF- production was only
slightly reduced in the presence of Tax (RAW-Tax and RAW-
Tax1) but was strongly inhibited in cells expressing TTP (RAW-
TTP). Coexpression of Tax reverted TTP inhibition and restored
high levels of TNF- (RAW-TaxTTP and RAW-Tax1TTP).
Together, these experiments illustrate a complex interplay
between Tax and TTP in macrophages. Under unstimulated
conditions, TTP reduces TNF- expression activated by Tax,
whereas in the presence of LPS Tax reverts the inhibition
induced by TTP.
DISCUSSION
In this article, we demonstrated that TTP interacts directly
with the oncoviral Tax transactivator proteins. TTP, which is
also known as Nup475 or TIS11, is encoded by an immediate-
early response gene that is induced by a variety of mitogens and
growth factors, including serum, phorbol esters (phorbol myris-
tate acetate [PMA]), insulin, and platelet-derived growth factor
(PDGF) (68–73). The TTP protein is widely distributed, with
particularly high levels of expression in lymph nodes, thymus,
and spleen (70). In addition, TTP transcription occurs in freshly
isolated BLV-infected lymphocytes and in HTLV-1 cell lines
(data not shown). TTP is predominantly localized in the nucleus
of quiescent fibroblasts and macrophages but translocates rap-
idly to the cytoplasm upon cell stimulation (58,63). Deficiency
of TTP results in a complex inflammatory syndrome in mice that
is characterized by an excess of circulating TNF- that can be
prevented by repeated injections of antibodies to TNF- (58).
Macrophages derived from these knockout mice exhibit en-
hanced TNF- mRNA stability and subsequent increase of the
corresponding protein (58).
At the molecular level, TTP binds to AU-rich elements lo-
cated in the 3 UTR of the TNF- mRNA and provokes its
destabilization (65,66). Interaction between TTP and RNA re-
quires the integrity of unusual CX8CX5CX3H zinc fingers lo-
cated at residues 109–128 and 147–166 in TTP (65,66,74).
These structures are not required for Tax binding because we
mapped the region involved in the interaction at the carboxyl-
terminal end of the TTP protein (Fig. 1, D). It thus appears that
the Tax protein probably does not compete directly with TTP for
RNA binding. The dissociation between the RNA- and Tax-
interaction domains of TTP instead supports an indirect mech-
anism of inhibition of TTP function. Alternatively, Tax may
interfere with TTP/RNA complex formation by directly disrupt-
ing intra-molecular conformational changes of the TTP protein.
An indirect mechanism of TTP inhibition is, however, also
supported by our confocal microscopy experiments. Coexpres-
sion of Tax and TTP was indeed associated with a delocalization
of the TTP protein and its partial retention into the nucleus (Fig.
2), suggesting that inhibition of TTP function could result from
a modification of its subcellular targeting. Furthermore, redistri-
bution of TTP was accompanied by an almost perfect colocal-
ization with Tax proteins in a region essentially concentrated
around the nucleus but detectable throughout the cell. In fact,
this phenotype is dependent on the cell type because HEK 293
fibroblasts did not exhibit the same pattern (data not shown). In
addition, the Tax proteins neither co-immunoprecipitated with
TTP in these cells nor inhibited TTP function, suggesting the
possible involvement of other factors required for complex for-
mation (75).
Fig. 5. Expression of tumor necrosis factor- (TNF-) induced by Tax in
macrophages. A) RAW 264.7 cells (RAW) stably transfected with pSG5 (RAW-
pSG5), pSGTax (RAW-Tax), pTax1 (RAW-Tax1), pSGTTP (RAW-tristetraprolin
[TTP]), or combinations of them (RAW-TaxTTP and RAW-Tax1TTP) were
cultivated for 6 hours, and TNF- expression was determined from the culture
supernatants by using an enzyme-linked immunosorbent assay (ELISA). Results
(in picograms per milliliter) are the means of two experiments done in triplicate.
Under these unstimulated conditions, TTP reduces TNF- expression induced by
Tax. B) RAW stably transfected with RAW-pSG5, RAW-Tax, RAW-Tax1,
RAW-TTP, RAW-TaxTTP, and RAW-Tax1TTP were cultivated for 6 hours
in the presence of lipopolysaccharide. TNF- expression was determined from
the culture supernatants by using an ELISA. Results (in picograms per milliliter)
are the means of two experiments done in triplicate. In the presence of lipo-
polysaccharide (LPS-stimulated), Tax reverts the inhibition induced by TTP.
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Functional interplay between Tax and TTP has been observed
not only in HeLa cells but also in RAW 264.7 macrophages and
in primary rat embryo fibroblasts. In these latter cells, Tax
induces immortalization and, in cooperation with activated Ha-
Ras, yields complete transformation (42,43). Interestingly, co-
expression of TTP inhibited oncogenesis initiated by Tax and
Ha-Ras (data not shown), indicating that TTP may participate in
a process of cellular protection against cell transformation. Sim-
ilarly, because TTP is predominantly localized in the nucleus of
quiescent fibroblasts (58,63), Tax-induced redistribution of TTP
could result in exit from the cell cycle and entry into a resting
stage. In other words, TTP could be part of a cellular mechanism
that interferes with proliferation of the infected cells and there-
fore could belong to a feedback loop process that inhibits Tax
(Fig. 6). In this context, Gao et al. (76) indicated that CCCH-
type zinc finger proteins might have antiretroviral activities.
The fact that TTP function as well as both activities of Tax
(i.e., immortalization of primary rat embryo fibroblasts and
transactivation of viral expression) were concomitantly affected
by their interactions is noteworthy. Although a general quench-
ing effect on gene expression by TTP could account for inhibi-
tion of Tax transactivation, control promoters (RSV and
3XTRE) were not modulated under the same conditions, sup-
porting a specificity of this effect (Fig. 3). Furthermore, the
immortalization and transactivation functions of Tax, both of
which are affected by TTP, are independent (55). Because Tax
interacts with specific subunits of the proteasome (77–80), a
straightforward interpretation is that the Tax/TTP complex is
targeted to this organelle and is subject to simultaneous proteo-
lytic degradation. Our preliminary results indeed indicate that
the stabilities of Tax and TTP are reduced when both proteins
are coexpressed (data not shown). In this context, variations in
the stoichiometry between the Tax proteins and TTP or their
respective kinetics could differentially affect the function of one
protein over the other. Evidence for antagonistic effects resulting
from TTP/Tax interactions was obtained by titrating TNF-
synthesized by macrophages containing both proteins (Fig. 5).
Under LPS-stimulated conditions, TTP-dependent inhibition of
TNF- expression was reverted by ectopic expression of Tax
(Fig. 5, B). Of note, the relative induction of TNF- in the
presence of Tax appeared to be lower than in its absence,
possibly due to its potential toxicity (compare panels A and B:
from 20 pg/mL to 5000 pg/mL for RAW-pSG5 versus 120–150
pg/mL to only 2500–3000 pg/mL for RAW-Tax). In contrast,
Tax stimulation of TNF- was abrogated by TTP (Fig. 5, A).
Together, our results reveal a remarkable bipartite interplay
between the functions of the Tax oncoproteins and TTP (Fig. 6).
The inhibition of TTP by Tax resulted in the stabilization of
AU-rich element–containing mRNAs (Fig. 4) and an increase in
the TNF- protein levels in macrophages (Fig. 5). It thus appears
that TNF- is regulated at two different levels: post-
transcriptional (this study) and initiation of mRNA transcription
(81). It should be mentioned that, under our experimental con-
ditions, we could not detect any significant transcriptional reg-
ulation using a reporter construct containing the TNF- pro-
moter in RAW 264.7 cells (data not shown). The finding that
TNF- expression is dually regulated by the Tax proteins un-
derlines the importance of this cytokine in the pathogenic mech-
anisms associated with HTLV-1 and BLV. And indeed, TNF-
protein levels are increased in species infected by these viruses
(9,10,13,14,82–85). TNF- is an inflammatory cytokine whose
downstream signaling is characterized by opposing effects [re-
viewed, for instance, in (86–88)]. The TNF- pathways bifur-
cate at the type I and II receptors, leading either to caspase
8–dependent apoptosis or, alternatively, to NF-B activation
and rescue from cell death (Fig. 6).
Although the role of TNF- during pathogenesis is not fully
understood, our data cast light on the mechanisms by which two
retroviruses (i.e., HTLV-1 and BLV) infecting different cell
types (T or B lymphocytes) are able to modulate TNF- expres-
sion. This observation is of importance for the cell transforma-
tion process induced by leukemogenic retroviruses because
TNF- overexpression plays a central role in pathogenesis.
Importantly, other cytokines, like granulocyte–macrophage
colony-stimulating factor and IL-3, are also subject to TTP-
dependent regulation (65,89–92) and are involved in oncoviral
pathogenesis (11,82,84,93–98). Modulation of TTP activity by
the Tax proteins could thus initiate a much broader range of
effects on various cytokines, leading ultimately to pathogenesis.
Stabilization of short-lived mRNAs coding for a series of cyto-
kines thus appears to be an important aspect of the pleiotropic
effects associated with the Tax proteins.
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